newsfilter
← Latest News
GlobeNewswire·

Foghorn Therapeutics to Participate in the Citizens Life Sciences Conference

CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (NASDAQ:FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting